Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 4;113(9):1177-1185.
doi: 10.1093/jnci/djab041.

Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles

Affiliations

Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles

Kai Wang et al. J Natl Cancer Inst. .

Abstract

Background: It remains unknown whether the benefit of colonoscopy screening against colorectal cancer (CRC) and the optimal age to start screening differ by CRC risk profile.

Methods: Among 75 873 women and 42 875 men, we defined a CRC risk score (0-8) based on family history, aspirin, height, body mass index, smoking, physical activity, alcohol, and diet. We calculated colonoscopy screening-associated hazard ratios and absolute risk reductions (ARRs) for CRC incidence and mortality and age-specific CRC cumulative incidence according to risk score. All statistical tests were 2-sided.

Results: During a median of 26 years of follow-up, we documented 2407 CRC cases and 874 CRC deaths. Although the screening-associated hazard ratio did not vary by risk score, the ARRs in multivariable-adjusted 10-year CRC incidence more than doubled for individuals with scores 6-8 (ARR = 0.34%, 95% confidence interval [CI] = 0.26% to 0.42%) compared with 0-2 (ARR = 0.15%, 95% CI = 0.12% to 0.18%, Ptrend < .001). Similar results were found for CRC mortality (ARR = 0.22%, 95% CI = 0.21% to 0.24% vs 0.08%, 95% CI = 0.07% to 0.08%, Ptrend < .001). The ARR in mortality of distal colon and rectal cancers was fourfold higher for scores 6-8 than 0-2 (distal colon cancer: ARR = 0.08%, 95% CI = 0.07% to 0.08% vs 0.02%, 95% CI = 0.02% to 0.02%, Ptrend < .001; rectal cancer: ARR = 0.08%, 95% CI = 0.08% to 0.09% vs 0.02%, 95% CI = 0.02% to 0.03%, Ptrend < .001). When using age 45 years as the benchmark to start screening, individuals with risk scores of 0-2, 3, 4, 5, and 6-8 attained the threshold CRC risk level (10-year cumulative risk of 0.47%) at age 51 years, 48 years, 45 years, 42 years, and 38 years, respectively.

Conclusions: The absolute benefit of colonoscopy screening is more than twice higher for individuals with the highest than lowest CRC risk profile. Individuals with a high- and low-risk profile may start screening up to 6-7 years earlier and later, respectively, than the recommended age of 45 years.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Multivariable-adjusted 10-year cumulative incidence (left panel) and mortality (right panel) of colorectal cancer (CRC) and the corresponding absolute risk reduction (ARR) according to CRC risk score. CRC risk score (range = 0-8) was defined as the number of the 8 CRC high-risk factors: having a family history of CRC among the first-degree relatives, no regular use of aspirin (<2 tablets or times per week), tall stature (upper 50% of height in each cohort), overweight or obesity (body mass index ≥25.0 kg/m2), current smoker or past smoker with 5 or more pack-years, low physical activity (<30 min/d of moderate-to-vigorous intensity activity), heavy alcohol intake (≥1 drink [14 g alcohol] per day for women and ≥2 drinks per day for men), and unhealthy diet (meeting <3 of the 6 dietary recommendations by the World Cancer Research Fund/American Institute for Cancer Research Report 2018, which included red meat <0.5 serving per day, processed meat <0.2 serving per day, dietary fiber ≥30 g/d, dairy products ≥3 servings per day, whole grains ≥48 g/d or account for at least one-half of total grains, and calcium supplement use). Trend in the ARRs across CRC risk scores was examined by regressing the multivariable-adjusted cumulative risk on baseline colonoscopy screening status and CRC risk score as well as their product term, whose P value was derived as the Ptrend. The tests were 2-sided. Error bars indicate 95% confidence intervals.
Figure 2.
Figure 2.
Multivariable-adjusted 10-year cumulative mortality of colorectal cancer (CRC) by subsite and corresponding absolute risk reduction according to CRC risk score. CRC risk score (range = 0-8) was defined as the number of the 8 CRC high-risk factors: having a family history of CRC among the first-degree relatives, no regular use of aspirin (<2 tablets or times per week), tall stature (upper 50% of height in each cohort), overweight or obesity (body mass index ≥25.0 kg/m2), current smoker or past smoker with 5 or more pack-years, low physical activity (<30 min/d of moderate-to-vigorous intensity activity), heavy alcohol intake (≥1 drink [14 g alcohol] per day for women and ≥2 drinks per day for men), and unhealthy diet (meeting <3 of the 6 dietary recommendations by the World Cancer Research Fund/American Institute for Cancer Research Report 2018, which included red meat <0.5 serving per day, processed meat <0.2 serving per day, dietary fiber ≥30 g/d, dairy products ≥3 servings per day, whole grains ≥48 g/d or account for at least one-half of total grains, and calcium supplement use). Trend in the ARRs across CRC risk scores was examined by regressing the multivariable-adjusted cumulative risk on baseline colonoscopy screening status and CRC risk score as well as their product term, whose P value was derived as the Ptrend. The tests were 2-sided. Error bars indicate 95% confidence intervals.
Figure 3.
Figure 3.
Multivariable-adjusted 10-year cumulative incidence of colorectal cancer (CRC) by age in all participants and according to CRC risk score. The crossed solid straight lines indicate the 10-year cumulative incidence of CRC of 0.47% in the whole study population at age 45 years, when CRC screening is recommended to start. The crossed dash straight lines indicate the corresponding incidence of 0.68% at age 50 years. Individuals with a CRC risk score of 0-2, 3, 4, 5, and 6-7 reached the age 45 years threshold risk at age 51 years, 48 years, 45 years, 42 years, and 38 years, respectively. CRC risk score (range = 0-8) was defined as the number of the 8 CRC high-risk factors: having a family history of CRC among the first-degree relatives, no regular use of aspirin (<2 tablets or times per week), tall stature (upper 50% of height in each cohort), overweight or obesity (body mass index ≥25.0 kg/m2), current smoker or past smoker with 5 or more pack-years, low physical activity (<30 min/d of moderate-to-vigorous intensity activity), heavy alcohol intake (≥1 drink [14 g alcohol] per day for women and ≥2 drinks per day for men), and unhealthy diet (meeting <3 of the 6 dietary recommendations by the World Cancer Research Fund/American Institute for Cancer Research Report 2018, which included red meat <0.5 serving per day, processed meat <0.2 serving per day, dietary fiber ≥30 g/d, dairy products ≥3 servings per day, whole grains ≥48 g/d or account for at least one-half of total grains, and calcium supplement use).

Comment in

References

    1. Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30. - PubMed
    1. Baxter NN, Goldwasser MA, Paszat LF, et al.Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1):1–8. - PubMed
    1. Atkin WS, Edwards R, Kralj-Hans I, et al.; UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–1633. - PubMed
    1. Zauber AG, Winawer SJ, O'Brien MJ, et al.Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687–696. - PMC - PubMed
    1. Baxter NN, Warren JL, Barrett MJ, et al.Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol. 2012;30(21):2664–2669. - PMC - PubMed

Publication types